Biomarkers for liver fibrosis post‐liver transplantation

Subtitle:not as easy as it looks

Liver biopsy remains key in the evaluation of hepatic dysfunction in liver transplant recipients. Concerns about its invasive nature and potential risks limit its acceptance by patients. Sampling error is another concern. Expert interpretation by an experienced pathologist is also necessary to optimize its utility. Despite these limitations, it retains an important role in manging patients. (1) However, development of markers of liver injury is an important area of investigation.

Publication year:2021

Keywords:Editorial

Accessibility:Open